Results 131 to 140 of about 2,089,346 (276)
Composite Iodine-gold Nanoparticles as a Contrast Agent in Computed Tomography
Journal of Medical PhysicsPurpose: Solutions of iodine-based compounds, due to their high X-ray attenuation coefficient, are widely used as contrast agents in computed tomography (CT) imaging.
Rezvan Ravanfar Haghighi +6 more
doaj +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Groups of Agents with a Leader [PDF]
We describe simulations of groups of agents that have to reach a target in a two dimensional environment, the performance criterion being the time taken by the last agent to reach the target.
Domenico Parisi +2 more
core
Molecular Oncology, EarlyView.We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Molecular Oncology, EarlyView.Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Therapeutics and Clinical Risk Management, 2019 Yunna Yang,1 Jing Zhang,2 Tong Li31Department of Neurosurgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100043, People’s Republic of China; 2Department of Neurosurgery, Beijing Friendship Hospital, Capital Medical University,
Yang Y, Zhang J, Li T
doaj
Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma
Molecular Oncology, EarlyView.PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga +2 more
wiley +1 more source
Molecular Oncology, EarlyView.Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Natural implementation with partially hones agents [PDF]
The paper proposes necessary and sufficient conditions for the natural implementation of(efficient) social choice correspondences (SCCs) in pure finite exchange economies when some ofthe agents are partially honest.
Lombardi Michele, Yoshihara Naoki
core +1 more source